Danaher Corporation $DHR Shares Sold by Bessemer Group Inc.

Bessemer Group Inc. trimmed its stake in Danaher Corporation (NYSE:DHR) by 11.8% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,242,237 shares of the conglomerate’s stock after selling 298,581 shares during the quarter. Danaher makes up 0.7% of Bessemer Group Inc.’s holdings, making the stock its 23rd largest holding. Bessemer Group Inc.’s holdings in Danaher were worth $442,932,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of DHR. GAMMA Investing LLC grew its holdings in shares of Danaher by 22.2% in the 1st quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate’s stock worth $1,871,000 after acquiring an additional 1,660 shares during the last quarter. Pacific Capital Partners Ltd purchased a new position in shares of Danaher during the first quarter valued at $7,175,000. Golden State Wealth Management LLC grew its holdings in shares of Danaher by 356.0% during the first quarter. Golden State Wealth Management LLC now owns 611 shares of the conglomerate’s stock valued at $125,000 after buying an additional 477 shares in the last quarter. Diversified Trust Co grew its holdings in shares of Danaher by 6.9% during the first quarter. Diversified Trust Co now owns 5,861 shares of the conglomerate’s stock valued at $1,202,000 after buying an additional 379 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Danaher by 25.1% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 94,833 shares of the conglomerate’s stock valued at $19,517,000 after buying an additional 19,031 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the business’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 11.20% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on DHR. Weiss Ratings reiterated a “hold (c-)” rating on shares of Danaher in a report on Friday. Rothschild & Co Redburn reiterated a “neutral” rating and set a $220.00 price target (down previously from $245.00) on shares of Danaher in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft lifted their price target on Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Redburn Partners set a $220.00 price target on Danaher in a report on Wednesday, October 8th. Finally, Cowen reiterated a “buy” rating on shares of Danaher in a report on Wednesday. Eighteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $243.39.

Danaher Price Performance

DHR opened at $223.03 on Monday. The stock has a market cap of $157.54 billion, a price-to-earnings ratio of 45.99, a PEG ratio of 3.41 and a beta of 0.77. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. The stock has a fifty day moving average price of $202.73 and a 200 day moving average price of $198.57.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. The firm had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s payout ratio is currently 26.39%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.